US Physical Therapy (USPH) Stock: Buy, Sell, or Hold?
$99.52
+0.28 (+0.28%)
▲
5d:
+11.59%
30d:
+16.48%
90d:
+20.25%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (22%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$82.85 – $93.51
Position: EXTENDED
Forward P/E & Valuation
29.6x
STRETCHED
vs 23.7x historical avg
Wall Street Target
$103.83
+4.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$84.26 / $101.18
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: USPH shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$130.75
Based on 10.6% avg growth
INTRINSIC VALUE TODAY
$81.19
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $99.52, which is considered extended relative to its 30-day fair value range of $82.85 to $93.51. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.6) compared to its historical average (23.7). At these levels, the market is pricing in 7.7% annual earnings growth.
Technical Outlook: Technically, USPH is in a strong uptrend. The price is approaching resistance at $101.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: USPH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, USPH is in a strong uptrend. The price is approaching resistance at $101.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: USPH scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$82.85 -
$93.51
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
22.4%
Trading Range & Key Levels
30-Day Trading Range
$82.85 -
$93.51
Current vs Trading Range
EXTENDED
Support Level
$84.26
Resistance Level
$101.18
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range (+6.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($103.83)
- BULLISH: Expecting earnings turnaround to 7.7% growth with 13.1% revenue growth
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
29.57
Wall Street Target
$103.83
(+4.6%)
Revenue Growth (YoY)
13.1%
Earnings Growth (YoY)
-56.5%
Profit Margin
3.6%
Valuation Premium vs History
+7.7% premium
PE vs Historical
29.6 vs 23.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.7%
(market-implied from PE analysis)
1-Year Target
$106.88
(+8%)
2-Year Target
$115.11
(+16%)
3-Year Target
$123.97
(+25%)
3-Yr Target (if PE normalizes)
(PE: 30→24)
PE COMPRESSION
$99.36
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.6, Growth: 17.1%)
$159.34
(+61%)
Base:
(SPY PE: 19.9, Growth: 17.1%)
$107.01
(+8%)
Bear:
(PE: 16.9, Growth: 17.1%)
$90.96
(-8%)
📈
Valuation based on Current Earnings
Forward PE: 29.24 | Forward EPS (Implied): $3.40
Bull Case
$120.13
(+21%)
Analyst growth 15.0%, PE expands to 30.7
Base Case
$99.49
(0%)
Market implied 0.0%, PE stable at 29.2
Bear Case
$76.11
(-24%)
Severe decline -15.0%, PE contracts to 26.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share USPH Analysis
Share this live USPH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 9:58 AM ET
Data refreshes hourly during market hours. Next update: 10:58 AM
Data refreshes hourly during market hours. Next update: 10:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 47 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 39 SELL |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 34 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive USPH Research Pages
